Hemab Therapeutics Holdings, Inc. (COAG) Ownership - Who Owns Hemab Therapeutics Holdings, Inc.?
Hemab Therapeutics Holdings, Inc. (COAG) Ownership Overview
- 25.74% Insiders
- 18.65% Mutual Funds
- 0.03% Other Institutional Investors
- 5.36% ETFs
- 50.21% Public Companies and Individual Investors
The ownership structure of Hemab Therapeutics Holdings, Inc. (COAG) stock is a mix of institutional, retail, and individual investors. Approximately 24.04% of the company’s stock is owned by Institutional Investors, 25.74% is owned by Insiders, and 50.21% is owned by Public Companies and Individual Investors.
The ownership structure of Hemab Therapeutics Holdings, Inc. (COAG) stock is a mix of institutional, retail, and individual investors. Approximately 24.04% of the company’s stock is owned by Institutional Investors, 25.74% is owned by Insiders, and 50.21% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 16, 2026 | Ra Capital Management, Llc | $1,689,818 | |
| May 20, 2026 | Ra Capital Management, Llc | $119,776 | |
| May 13, 2026 | Ra Capital Management, Llc | $159,036 | |
| May 10, 2026 | Ra Capital Management, Llc | $1,268,594 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Driehaus Capital Management Llc | $26,291,003 | |
| Jun 30, 2026 | Woodline Partners Lp | $5,510,969 | |
| Jun 30, 2026 | Soros Fund Mangment Llc | $918,250 | |
| Jun 30, 2026 | Deerfield Management Company, Lp | $10,100,750 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ra Capital Management, Llc | 7,808,627 | Insider | 16.72% | 323,667,589 |
| Peter Kolchinsky | 7,808,627 | Institution | 16.72% | 323,667,589 |
| A S Novo | 4,180,550 | Insider | 8.95% | 173,283,798 |
| Smallcap World Fund Inc | 3,506,543 | Institution | 7.51% | 145,346,207 |
| Vanguard | 892,752 | Institution | 1.91% | 37,004,570 |
| Fidelity Mt. Vernon Street Trust | 794,424 | Institution | 1.70% | 32,928,875 |
| Vanguard Index Funds | 759,094 | Institution | 1.63% | 31,464,446 |
| Fidelity Securities Fund | 741,048 | Institution | 1.59% | 30,716,440 |
| Ishares | 735,995 | Institution | 1.58% | 30,506,993 |
| Steve Weber | 715,791 | Institution | 1.53% | 29,669,537 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Smallcap World Fund Inc | 3,506,543 | Institution | 7.51% | 145,346,207 |
| Fidelity Mt. Vernon Street Trust | 794,424 | Institution | 1.70% | 32,928,875 |
| Vanguard Index Funds | 759,094 | Institution | 1.63% | 31,464,446 |
| Fidelity Securities Fund | 741,048 | Institution | 1.59% | 30,716,440 |
| Jpmorgan Trust Ii | 531,382 | Institution | 1.14% | 22,025,784 |
| Fidelity Select Portfolios | 504,476 | Institution | 1.08% | 20,910,530 |
| Fidelity Capital Trust | 439,953 | Institution | 0.94% | 18,236,052 |
| Fidelity Concord Street Trust | 233,170 | Institution | 0.50% | 9,664,897 |
| Fidelity Advisor Series Vii | 219,700 | Institution | 0.47% | 9,106,565 |
| T. Rowe Price Health Sciences Fund, Inc. | 206,840 | Institution | 0.44% | 8,573,518 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 555,543 | Institution | 1.19% | 17,132,946 |
| SPDR, XBI ETF | 538,024 | Institution | 1.15% | 21,746,930 |
| iShares, IWM ETF | 503,715 | Institution | 1.08% | 20,360,160 |
| Vanguard, VXF ETF | 199,972 | Institution | 0.43% | 6,167,136 |
| Vanguard, VTWO ETF | 115,109 | Institution | 0.25% | 3,549,962 |
| iShares, IWO ETF | 112,790 | Institution | 0.24% | 4,675,146 |
| Schwab, SCHA ETF | 92,724 | Institution | 0.20% | 3,747,904 |
| iShares, IWN ETF | 75,295 | Institution | 0.16% | 3,043,424 |
| T. Rowe Price, TMSL ETF | 39,958 | Institution | 0.09% | 1,615,102 |
| Fidelity, FFSM ETF | 36,403 | Institution | 0.08% | 1,664,709 |
FAQ
Who Owns Hemab Therapeutics Holdings, Inc. (COAG)?
According to the latest TipRanks data, approximately 24.04% of the company's stock is held by institutional investors, 25.74% is held by insiders, and 50.21% is held by public companies and individual investors.
What percentage of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.04% of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by institutional investors: 18.65% by mutual funds, 5.36% by ETFs and 0.03% by other institutional investors.
What percentage of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.21% of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by public companies and individual investors.
Who owns the most shares of Hemab Therapeutics Holdings, Inc. (COAG)?
Ra Capital Management, Llc owns the most shares of Hemab Therapeutics Holdings, Inc. (COAG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
